Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.The Review of Scientific Instruments|January 3, 2020
Multicolor femtosecond pump-probe system with single-electron sensitivity at low temperatures and high magnetic fieldsC Traum, P Henzler, S Lohner, et al.Cancer|February 1, 1975
Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanomaJ H Moon, S Gailani, M R Cooper, et al.Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.Physical Review Letters|May 23, 2015
Magneto-optics of massive dirac fermions in bulk Bi2Se3M Orlita, B A Piot, G Martinez, et al.Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.Cancer|January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, O Glidewell, et al.Pageof 14